Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$10.05 USD
+0.57 (6.01%)
Updated May 14, 2024 04:00 PM ET
Pre-Market: $10.09 +0.04 (0.40%) 8:08 AM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | -0.39 |
Last EPS Surprise | 9.30% |
ABR | 2.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.60 |
Next Year | -1.47 |
EPS (TTM) | -1.60 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.98M | 16.05M | 45.99M | 55.28M |
# of Estimates | 2 | 2 | 5 | 5 |
High Estimate | 20.80M | 20.80M | 83.30M | 87.60M |
Low Estimate | 11.16M | 11.29M | 6.73M | 12.77M |
Year ago Sales | 11.02M | 10.53M | 44.58M | 45.99M |
Year over Year Growth Est. | 45.01% | 52.37% | 3.18% | 20.19% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -0.39 | -1.60 | -1.47 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | -0.40 | -0.40 | -1.62 | -1.54 |
High Estimate | -0.40 | -0.38 | -1.55 | -1.18 |
Low Estimate | -0.41 | -0.40 | -1.67 | -1.64 |
Year ago EPS | -0.38 | -0.43 | -1.58 | -1.60 |
Year over Year Growth Est. | -7.89% | 9.30% | -1.27% | 8.13% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 2 | 2 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -0.39 | -1.60 | -1.47 |
7 Days Ago | -0.43 | -0.42 | -1.63 | -1.50 |
30 Days Ago | -0.43 | -0.42 | -1.63 | -1.50 |
60 Days Ago | -0.43 | -0.42 | -1.70 | -1.56 |
90 Days Ago | -0.40 | -0.40 | -1.83 | -1.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.39 | -1.57 | -1.45 |
Zacks Consensus Estimate | -0.41 | -0.39 | -1.60 | -1.47 |
Earnings ESP | 0.00% | 0.00% | 1.52% | 0.97% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.39 | -0.40 | -0.43 | -0.38 | NA |
Estimate | -0.43 | -0.46 | -0.38 | -0.38 | NA |
Difference | 0.04 | 0.06 | -0.05 | 0.00 | 0.01 |
Surprise | 9.30% | 13.04% | -13.16% | 0.00% | 2.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more